Dreamcraft Ventures has closed its €66M Fund II to invest in B2B software companies.
Its portfolio will have 3 core themes: B2B SaaS (e.g. Playable), Digital Entertainment (e.g. Hiber) and FinTech (e.g. Banking Circle, acquired by EQT). This focus doubles down on verticals in which Dreamcraft has invested previously.
Investments so far include:
Limited partners of Dreamcraft’s new fund consist of institutional investors from the Nordics such as Chr. Augustinus Fabrikker, as well as Family Offices and well-connected entrepreneurs.
Dreamcraft follows graduation-centric structure and supports its portfolio founders on critical operational topics from the first engagement. The firm has already made several investments in Germany and will continue building the bridge between the Nordics and Germany with ambitions of investing in broader Europe.
“We’re glad to have the continuous support and trust of our LPs to bring our investment and value-add approach – what we call venture engineering – from the Nordics to the European ecosystem.” said Carsten Salling, General Partner at Dreamcraft Ventures. “We’re convinced that VC is a craft, not an art, and we’re excited to be supporting the most ambitious founders across Europe with our structured and reliable investment approach.”
Managing Partner Daniel Mariussen said: “It’s about being a reliable partner for the founders. We’re strongly convinced that early-stage investing is a craft and it’s about getting the work done. We work hand-in-hand with founders to build successful ventures and support them towards Series A, even with the nitty-gritty things. Founders can rely on us and get the missing pieces in building what is needed to be built to graduate at pre-seed and seed stages.”
Europe’s biggest companies are predominantly found in “old” industries. It’s a trend we first spotted in our inaugural Fortune 500 Europe list last year
Another top tech company executive has warned the European regulators over the regulation of AI technology, saying that with the regulation, the block risks f
This strategic decision underscores Lisbon’s burgeoning reputation as a rising star among Europe’s tech hubs and aligns perfectly with Allianz's goals to en
Avenue Biosciences, a transatlantic biotechnology company specialising in novel protein engineering technologies, has raised a $2.5M seed financing round. Led